CORBIN THERAPEUTICS
Corbin Therapeutics is a provider of a drug discovery platform. The company's biotechnology platform develops drugs from ubiquitin carboxyl-terminal hydrolase 15 (USP15) enzyme to treat various inflammation-based diseases.
CORBIN THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Montreal, Quebec, Canada
Country:
Canada
Website Url:
http://www.corbinthera.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Microsoft Exchange Online Office 365 Mail GoDaddy DNS Person Schema GoDaddy SSL GoDaddy
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Current Employees Featured
Official Site Inspections
http://www.corbinthera.com Semrush global rank: 5.34 M Semrush visits lastest month: 1.56 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Corbin Therapeutics"
Corbin Therapeutics Company Profile 2024: Valuation, Funding ...
Corbin Therapeutics General Information Description. Operator of a biotechnology company intended to screen and identify novel inhibitors. The company develops enzyme inhibitors for …See details»
Corbin Therapeutics - Crunchbase Company Profile & Funding
Corbin Therapeutics is a biotechnology platform develops drugs from ubiquitin carboxyl-terminal hydrolase. View contacts for Corbin Therapeutics to access new leads and connect with …See details»
Corbin Therapeutics - Overview, News & Similar companies
Who is Corbin Therapeutics. Corbin Therapeutics is a Montreal-based biotechnology company, using a unique drug discovery platform to identify and develop novel USP15 inhibitor s for …See details»
Corbin Therapeutics Inc - LinkedIn
Corbin Therapeutics Inc | 219 followers on LinkedIn. Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform …See details»
Corbin Therapeutics Inc. - Amorchem
Corbin Therapeutics ( www.corbinthera.com) is a biotech company spun out from our USP15 program led by Dr. Philippe Gros at McGill University. Corbin uses a proprietary drug …See details»
Corbin Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Corbin Therapeutics is a drug discovery spin-off from Amorchem which engages in developing USP15 (ubiquitin carboxyl-terminal hydrolase 15 (USP15) enzyme) inhibitors for …See details»
Corbin Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Corbin Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:Targeting USP15 (Proteorex/Corbin).See details»
Company Information - RocketReach
Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation, …See details»
NEWS RELEASE - For immediate release AMORCHEM SPINS OUT …
Www.mcgill.ca-secondary institution. It has two campuses, 10 faculties, 300 programs of study and some 40,000 students, including more than 9,400 graduate students.See details»
Corbin Therapeutics - VentureRadar
Similar Companies: Luye Pharma Group China n/a Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, …See details»
Corbin Therapeutics and Proteorex Therapeutics announce a
May 19, 2017 Corbin Therapeutics is a Montreal -based biotechnology company, using a unique drug discovery platform to identify and develop novel USP15 inhibitors for treatment of various …See details»
AMORCHEM SPINS OUT ITS SEMA 3A TECHNOLOGY INTO …
Jan 11, 2017 Univalor (www.univalor.ca) is a university technology transfer organization. Since 2001, it commercializes scientific findings and technological innovations emanating from some …See details»
Articles about Corbin Therapeutics - BioSpace
May 19, 2017 Email: [email protected]. Show jobs for this employer About Corbin Therapeutics. Corbin Therapeutics is a Montreal-based biotech company, using a unique drug …See details»
Corbin therapeutics inc Reviews | Read Client Reviews of Corbin ...
Corbin therapeutics inc Review Reviews 12. 3.9See details»
Research collaboration to accelerate the development of new …
May 2, 2019 CQDM, Healthy Brains for Healthy Lives (HBHL), Corbin Therapeutics and Brain Canada award $1.5 million to McGill Professor Philippe Gros who will pursue the development …See details»
Corbin Therapeutics And Proteorex Therapeutics Announce A
May 19, 2017 Corbin Therapeutics And Proteorex Therapeutics Announce A Research And Development Collaboration To Discover Novel Ubiquitin-Specific Protease Inhibitors - read this …See details»
Corbin Therapeutics and Proteorex Therapeutics announce a …
May 21, 2017 TORONTO and MONTREAL, Canada I May 19, 2017 I Proteorex Therapeutics Inc. (“Proteorex”), headquartered in JLABS @ Toronto, is excited to announce the start of their …See details»
CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 …
Montreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue …See details»
University of Dundee and Corbin Therapeutics collaborate to …
May 22, 2017 /CNW Telbec/ - University of Dundee, its Drug Discovery Unit ("DDU"), and Corbin Therapeutics ("Corbin") are pleased to announce their collaboration agreement...See details»
CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 …
Montreal, May 2nd, 2019 - CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of theSee details»